Elena Ridloff
Director at Kymera Therapeutics, Inc. (KYMR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 11SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,000 | $87.00 | $261K | +20.4% |
| Apr 1SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 7,400 | $85.37 | $632K | +22.7% |
| Apr 1SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,4001,200 held (−74%) | $85.19 | $290K | +23.0% |
| Apr 1SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,200 | $86.05 | $103K | +21.8% |
- Sell
Director Elena Ridloff sold $261K of KYMR at $87.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Elena Ridloff sold $632K of KYMR at $85.37 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Elena Ridloff sold $290K of KYMR at $85.19 — cuts the stake by 74%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Elena Ridloff sold $103K of KYMR at $86.05 — pre-scheduled 10b5-1 plan sale.